Crispr Therapeutics: FDA Filing on Sickle Cell Gene Therapy Is Almost Done

An approval filing for a breakthrough treatment of sickle cell disease should be done by March, Crispr Therapeutics said, highlighting the company’s lead in a competitive area of medical research and ...

China’s Big Comeback Is Just Getting Started. How to Play It.

Talk about a comeback. As China abandons policies that stifled economic growth for the past three years, investors have sent the country’s stocks soaring—up more than 50% since October. The rally migh...

CVS eyes next-generation health clinics after Amazon’s move for One Medical

CVS Health Corp. is investing in a young chain of health clinics, and may be looking to acquire another. CVS CVS, -0.12% invested $100 million in a Carbon Health Inc., a San Francisco-based chain of u...

China Is Open Again. 13 Ways to Tap Into Its Recovery Right Now.

Chinese stocks look poised to keep bouncing into the Year of the Rabbit. As authorities peel back some of the last Covid restrictions this weekend and policy makers prioritize reviving the world’s sec...

It’s Pharma Time: Why Merck and Lilly Stock Are Buys, but not Pfizer.

My 2023 biotech outlook calls for continued momentum in name changes. I just need to figure out what the stocks will do. Last year, Respira Technologies became Qnovia. It’s run by a former tobacco exe...

Dialysis company DaVita stock suffering worst day in 22 years after big profit miss, disappointing outlook

Shares of DaVita Inc. plummeted in active trading Friday, toward their worst performance in more than two decades, after the dialysis company reported third-quarter that fell well below expectations a...

Teladoc stock surges after earnings as losses narrow

Shares of Teladoc Health Inc. were up about 13% in after-hours trading Wednesday after the telemedicine company posted a narrower loss than analysts were anticipating for its latest quarter, while sli...

Cano Health Stock Plumments on Report CVS Is Abandoning Purchase

Cano Health shares had their largest drop on record Monday following a report that CVS Health has walked away from a potential acquisition of the primary care provider. Dealreporter was the first to r...

Humana, CVS Circle Cano Health as Potential Buyers

Humana and CVS Health are circling Cano Health according to people familiar with the situation, as healthcare heavyweights scramble to snap up primary-care providers. The talks are serious and a deal ...

Intellia Investors Are Dumping Stock on News of Crispr Gene-Editing Success

Text size Intellia CEO John Leonard called the results a vindication of the company’s modular approach to Crispr therapies. Courtesy Intellia Therapeutics Patients who got a one-time gene-editin...

Nursing homes suing caregivers for debts they don’t owe, regulator says

Nursing homes and debt collectors are billing and suing long-term-care residents’ family members and friends, demanding payments for debts these individuals don’t legally owe, consumer attorneys and f...

Pfizer, Moderna Take Different Paths as Vaccine Boom Ends

Pfizer is trying to add $25 billion to its 2030 revenue through acquisitions. Dan Kitwood – WPA Pool/Getty Images Text size Pfizer ’s $5.4 billion deal to acquire the biotech Global Blood Therap...

Pfizer in Advanced Talks to Buy Global Blood Therapeutics for About $5 Billion

Pfizer is in advanced talks to buy Global Blood Therapeutics the maker of a recently approved drug for sickle-cell disease, for about $5 billion, in the latest move by the drug giant to bolster its po...

Teladoc Stock Sinks on Wider Loss and Weak Guidance

Teladoc Health was falling more than 23% in premarket trading Thursday after the remote healthcare provider posted a wider-than-expected quarterly loss after recording a $3 billion impairment charge. ...

Teladoc loses $3 billion in three months, stock plummets 24%

Shares of Teladoc Health Inc. plunged more than 24% in after-hours trading Thursday after the telehealth company took another multibillion-dollar impairment charge, helping to bring its total losses f...

25 Stocks That Could Rise on a Short Squeeze

Investors betting against electric-vehicle stocks take note: Five of 25 stocks that short-selling research firm S3 Partners identified this month as being at risk of a short squeeze are in the EV busi...

How Amazon’s $3.9 billion wager on primary care could change your Prime membership

Amazon’s AMZN, +1.52% $3.9 billion acquisition of One Medical ONEM, +69.45% is the e-commerce giant’s biggest bet on healthcare to date, and it hints at a future in which primary care and streaming op...

Five Beaten-Up Biotech Stocks Saw Big Share Purchases

Text size Biotech stocks Kymera, Cullinan Oncology, Repare, Iovance, and Kodiak Sciences are all in the red so far this year, but they’ve seen large stock buys. Dreamstime Biotech stocks have taken so...

My parents-in-law sold their home and bought an RV. They have $200K in the bank. How can they protect their assets from being used for nursing-home costs?

My father-in-law has health issues. While he is not quite ready for a nursing home, that may be a necessity in the near future. He has state retirement benefits and a very small Social Security check....

Carvana, Robinhood and Teladoc Stock Give Way to Old-School Rivals. Here’s When It Might Be Safe to Buy.

Text size Carvana’s stock has fallen nearly 80% in the past 12 months. Mark Ralston/AFP/Getty Images It’s new school versus old school, and the new school doesn’t stand a chance. No, we’re not talking...

Cathie Wood’s ARK Bet Big on Tumbling Teladoc. These Funds Did Too.

Text size A Teladoc member visits virtually with a doctor. Courtesy of Teledoc Cathie Wood’s ARK Invest and other institutional investors were slated to take a steep hit as shares of Teladoc Health pl...

Teladoc stock plunges more than 30% after earnings outlook slashed, massive impairment charge

Shares of Teladoc Health Inc. were slammed in after-hours trading Wednesday, after the telemedicine company took an impairment charge of more than $6.5 billion and slashed its full-year outlook. Telad...

Cathie Wood’s Flagship Fund Is Down 45% This Year. Money Is Still Flowing In.

Cathie Wood’s ARK Innovation exchange-traded fund keeps falling, but investors aren’t jumping ship. Shares of the popular ETF, which is known by its ticker ARKK, have declined 45% so far in 2022—inclu...

Why did the stock market fall? Dow finishes nearly 1,000 points lower in worst day since October 2020

U.S. stocks fell sharply on Friday to suffer their biggest one-day drop since 2020, as investors continued to weigh hawkish comments on interest rates a day earlier by Federal Reserve Chairman Jerome ...

Teladoc Stock Has Tumbled. Goldman Sachs Sees a Major Recovery.

Text size Teladoc stock is set for a big comeback, says Goldman Sachs. Courtesy of Teladoc Teladoc Health stock has shed half its value in the past six months. An analyst at Goldman Sachs says it’s ti...

Tech Stocks Got Hit Hard. Where to Find Bargains Now.

The technology sector may not be on sale, but it certainly has gotten cheaper lately. Major technology stocks like Apple (ticker: AAPL), Alphabet (GOOGL), Microsoft (MSFT), and Meta Platforms (FB) are...

Where to Find Bargains Among Tech and Growth Stocks

The technology sector may not be on sale, but it certainly has gotten cheaper lately. Major technology stocks like Apple (ticker: AAPL), Alphabet (GOOGL), Microsoft (MSFT), and Meta Platforms (FB) are...